A 72-year-old patient says her side effects got far worse after her telehealth site switched compounders, as an estimated 5 million Americans now use compounded GLP-1s.
Recap by typeshit. Full story at Time Magazine.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A preprint using health records found BPC-157 users rose from about 54 in early 2022 to 1,018 in early 2026, and most waited two months to tell a doctor.
New WHO childhood obesity guidance cites unknown effects on growth and mental health, while Novo, Lilly, AstraZeneca and Pfizer keep testing the drugs in kids.
Loading…